To hear about similar clinical trials, please enter your email below
Trial Title:
Acute Myeloid Leukemia Registry
NCT ID:
NCT05979675
Condition:
Acute Myeloid Leukemia
Conditions: Official terms:
Leukemia
Leukemia, Myeloid
Leukemia, Myeloid, Acute
Study type:
Observational [Patient Registry]
Overall status:
Recruiting
Study design:
Time perspective:
Prospective
Summary:
All acute myeloid leukemia (AML) patients diagnosed after 1 Jan 2020 will be included to
this study.
Detailed description:
This is a non interventional prospective disease registry, 250 prospective patients
diagnosed with AML across 20 centers in Turkey.
Participating sites will consist of hematology clinics and routine follow-up procedures
will be followed-up.
All patients diagnosed after 1 Jan 2020 as AML will be included and patients will be
enrolled during 24 months of period and will be followed-up 36 months. Study will be
completed in 60 months.
Criteria for eligibility:
Study pop:
All AML patients diagnosed after 1 Jan 2020 will be included to this study.
Sampling method:
Non-Probability Sample
Criteria:
Inclusion Criteria:
- Diagnosed as AML after 1 Jan 2020
- Patients signed informed consent form
Exclusion Criteria:
- Patients under 18 years old
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
Antalya Training and Research Hospital
Address:
City:
Antalya
Country:
Turkey
Status:
Recruiting
Contact:
Last name:
Volkan Karakus
Contact backup:
Email:
dr_v_karakus@yahoo.com
Investigator:
Last name:
Volkan Karakus
Email:
Principal Investigator
Start date:
December 21, 2021
Completion date:
December 21, 2026
Lead sponsor:
Agency:
Turkish Hematology Association
Agency class:
Other
Source:
Turkish Hematology Association
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05979675
